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Temperature sensitivity for conformation is an intrinsic property of
wild-type p53
P Hainaut, S Butcher and J Milner
Department ofBiology, University of York, Heslington, York YOJ 5DD, UK.
Symmay The tumour-suppressor protein p53 is a metal-binding transcription factor with sequence-specific
DNA-binding capacity. In cancer. mutation of p53 disrupts protein conformation with consequent loss of
DNA binding and associated tumour-suppressor function. In vitro, the conformation and DNA-binding
activity ofwild-type p53 are subject to redox modulation and are abrogated by exposure to metal chelators. In
the present study, we have used the chelator 1, l-phenanthroline (OP) to probe the effect of temperature on
the conformational stability of p53 translated in vitro. Wbereas low temperature (30-C) stabilised wild-type p53
conformation and protected against chelation, high temperature (41-C) promoted destabilisation and enhanced
chelation, indicating that temperature influences the folding of wild-type p53. Destabilisation of p53 tertiary
structure induced protein aggregation through hydrophobic interactions, consistent with the notion that
wild-type p53 contains a hydrophobic core which may become exposed by metal chelation. These results
indicate that temperature sensitivity for conformation is an intrinsic property of wild-type p53 and suggests
that small changes in temperature may directly affect p53 function.
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The tumour-suppressor protein p53 plays a role in the cont-
rol of cell proliferation, differentiation and survival after
DNA damage (for review see Levine et al., 1994). p53 is a
sequence-specific transcriptional regulator which transac-
tivates genes such as GADD45 (Kastan et al., 1992), MDM-
2 (Momand et al., 1992) and WAF-l (El-Deiry et al., 1993).
The last encodes a 21 kDa protein which binds to G1 cyclin-
dependent kinases and blocks their activity, thus acting as a
negative regulator of the cell cycle. The capacity to bind
DNA and transactivate gene expression is altered in p53
mutants associated with cancer (Bargonetti et al., 1991; Kern
et al., 1992).
Specific DNA binding is restricted to oligomeric forms of
p53 which adopt a specific tertiary structure characterised by
reactivity with a monoclonal antibody recognising a con-
formation-dependent epitope, PAb 1620 (plus PAb 246 for
murine p53) (see review in Milner, 1994). Disruption of this
structure by protein denaturation or by mutations associated
with cancer result in exposure of a primary epitope recog-
nised by PAb 240 (Gannon et al., 1990; Stephen and Lane,
1992). The DNA-binding domain is located in the central
portion of the molecule (residues 102-292 of human p53,
Pavletich et al., 1993). This domain encompasses evolu-
tionary conserved regions 2-5, is conformationally flexible
and contains zinc (Hainaut and Milner, 1993a,b; Halazonetis
and Kandil, 1993; Pavletitch et al., 1993, Cho et al., 1994).
Zinc binding to conserved cysteine and histidine residues
within this domain stabilises a tertiary structure involved in
contacting DNA. The recently published crystal structure of
the central portion of human p53 in complex with DNA
indicates that the DNA-binding domain consists of two P-
sheets which serve as a scaffold for two large loops and a
loop-sheet-helix motif (Cho et al., 1994). The two large
loops are connected by a tetrahedrally coordinated zinc
atom. Together with the loop-sheet-helix motif, these loops
form the DNA-binding surface of p53 (Cho et al., 1994). The
crucial role of zinc in stabilising this structure suggests that
factors affecting the metal-dependent folding of p53 may also
regulate its activity. Indeed, we have shown that chelating
and oxidising agents disrupt the PAb 1620 + conformation
of p53 and inhibit specific DNA binding (Hainaut and
Milner, 1993a,b).
The ability of a given chelator to disrupt wild-type p53
conformation depends upon its concentration and reflects (i)
its affinity for metal ions and (ii) their accessibility within the
protein structure. Thus, factors which affect the stability of
the metal-dependent structure may also modulate the concen-
tration of chelator required to disrupt the conformation of
the wild-type protein. In the present study, we have used the
metal chelator 1,10-phenanthroline (OP) to probe the effect
of temperature on the conformational stability of wild-type
p53. We report that small changes in temperature profoundly
affect the conformational stability of wild-type p53, suggest-
ing that the protein is intrinsically temperature sensitive for
conformation.
Materials and methods
Translation and sizefractionation ofp53
Plasmids pSP6p53"'35 (munrne wild-type p53), pSP6p53i"35
(munrne temperature-sensitive mutant; Michalovitz et al.,
1990; Milner and Medcalf, 1990), p53 H8 (human wild-type
p53; Harrs et al., 1986) and p53H861 (human temperature-
sensitive mutant p53-73; Medcalf et al., 1992) were used to
generate RNA for subsequent translation in rabbit
reticulocyte lysate (Promega) in the presence of 0.75 tLM
[35S]methionine (40.5 TBq mmol-', Amersham). The amount
of p53 synthesised in a typical reaction was 15-30ngmg'I
lysate protein (3-6ngl.1' reticulocyte lysate). After 1 h,
translations were stopped with anisomycin (2jLg;lI 1) and
aliquots of lysate were exposed for 20 min to 1,10-
phenanthroline (OP, Sigma) kept as a 20 mM solution in
10 mM Tris-HCI, pH 7. Oligomers of p53 were separated by
gel filtration onto Superose 6 (Pharmacia) as described
previously (Milner et al., 1991; Hainaut et al., 1994).
Analysis ofp53 conformation and DNA-binding activity
Protein conformation was determined by immunoprecipita-
tion with specific monoclonal antibodies as described (Cook
and Milner, 1990). Sequence-specific DNA binding was
assayed by electromobility shift assay (EMSA) using as target
the double-stranded oligonucleotide 5'-GGGCATGTCCGG-
GCATGTCC-3' (p53 CON; Funk et al., 1992) as described
previously (Hainaut and Milner, 1993b). All assays were
performed in the presence of PAb 421, which retards and
stabilises p53-DNA complexes (Funk et al., 1992; Hainaut
and Milner, 1993b).
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Western blotting ofcellular p53
The T3T3 murine fibroblastic cell line expresses high levels of
p53 in the wild-type conformation (Milner et al., 1993).
SV3T3 expresses high levels ofwild-type p53 in complex with
the SV40 large T antigen (Milner et al., 1993). Cells at 75%
confluence were extracted on ice in 10 mM Trs-HCI,
140mM sodium chloride, containing dithiothreitol 2 mM
(DTT), 0.5% NP40, 5 ig mlP' leupeptin, 500 U ml-' trasylol
(aprotinin) and 200gM phenylmethylsuiphonyl fluoride
(PMSF). Extracts were exposed to 3 mM OP for 20min at
37C and analysed by immunoprecipitation with antibodies
to p53. Immunoprecipitates were analysed on 15% sodium
dodecyl sulphate-polyacrylamide gel eectrophoresis (SDS-
PAGE), transferred to nitrocellulose and p53 was detected
with anti-p53 antibodies PAb 421, PAb 240 and RA3-2C2
(Wade-Evans and Jenkins, 1985; Yewdell et al., 1986; Gan-
non et al., 1990) and "NI-labelled protein A as described
elsewhere (Gamble and Milner, 1988).
Resuts
Disruption ofwild-type p53 conformation by OP is afunction
oftemperature
Chelation by OP disrupts wild-type p53 conformation, as
shown by loss ofreactivity with antibodies PAb 246 and PAb
1620 and inhibition of sequence-specific DNA binding
(Hainaut and Milner, 1993a,b). We now show that the extent
of OP-induced disruption is a function of temperature.
Murine wild-type p53 translated in vitro at 37C was exposed
for 20 min to OP at either 30'C or 37C. At 3rC, exposure
to increasing concentrations of OP induced p53 to become
non-reactive with PAb 246 (and with PAb 1620, data not
shown) and inhibited DNA-binding activity. However, the
protein was at least partially resistant to OP when the same
experiment was performed at 30 C (Figure la and b). In
contrast, raising temperature to 41'C enhanced the effect of
OP, as shown by a reduction of the half-maximally effective
concentration (EC50) of OP from 1.25 mM at 3rC, to 0.5 mM
at 41'C (Figure 2a). Moreover, incubation at 43'C induced
murine p53 to adopt a mutant-like conformation even in the
absence of OP, and this effect was not reversed by shifting
temperature back to 3TC (data not shown). These results
show that temperature directly influences the specific folding
of wild-type p53. Whereas low temperature (30-C) stabilises
p53 and protects against chelation, high temperature (41C)
promotes destabilisation and enhances chelation.
Sensitivity to temperature andchelation discrininates between
different genotypes ofp53 in the wild-type conformation
The murine mutant p53v'13 is temperature sensitive for func-
tion in intact cells (Michalovitz et al., 1990; Martinez et al.,
1991). When translated in vitro, this protein adopts the PAb
246+ conformation at 30'C (Milner and Medcalf, 1991).
Upon incubation with OP at 30-C, p53'131 was found to be
much more sensitive to chelation than wild-type p53
(EC5o = 0.5 mM compared with >2.5 mM for wild-type p53;
Figure 2a and b). A conformational stability similar to that
of wild-type p53 at 3TC (EC5o = 1.25 mM) was observed at
25-C (Figure 2b). Thus, the PAb 246+ conformation of
p531153l differs from that of wild-type by its sensitivity to
temperature and to chelation.
Compatible results were observed with human p53 (Figure
2c and d). Resistance of human wild-type p53 to OP was
increased by lowering temperature from 37C to 30'C (Figure
2c). The human mutant p53ku73, which is conformationally
temperature sensitive in vitro (Medcalf et al., 1992), also
exhibits a dereased sensitivity to OP at 25C as compared
with 30-C (Figure 2d). Note that human p53 was more
sensitive to OP than mouse p53 (the EC5( of OP at 37C is
0.5 mM for human p53 and 1.25 mM for mouse p53).
Overall, these results indicate that the stability of the PAb
246+ conformation of p53 is a function of temperature. We
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Flgwe 1 Disruption of wild-type p53 conformation by OP is a
function of temperature. Murine wild-type p53 was translated in
vitro at 3TC in the prsence of p-Slmethionine and aliquots of
translated lysate were exposed to varying concentrations of OP
for 20min at either 30'C or 3TC. (a) Reactivity with PAb 246
was determined by immunoprecipitation and SDS-PAGE ana-
lysis on 15% gels under reducing conditions. Identical results
were obtained with PAb 1620 (not shown). (b) Equivalent ali-
quots of each experimental conditions were assayed for binding
to 32P-1abelled double-stranded oligonucleotide 5'-GGGCAT-
GTCCGGGCATGTCC-3'. All reactions were carried out in the
presence of PAb 421, which supershifts and stabilises p53-DNA
complexes (see Materials and methods). EMSAs were performed
by electrophoresis on 4% polyacylamid ges Only the top of
the autoradiogram, which shows P-rdioactivity associated with
p53-DNA complexes, is shown.
suggest that temperature regulates the access of the chelator
to the metal ions structurally bound to p53 by influencing the
stability of the protein structure which surrounds the sites
involved in metal liganding.
Metal chelation induces the disruption ofa hydrophobic protein
structure
Removal ofmetal ions by chelation promotes cysteine oxida-
tion and p53 cross-linking by disulphide bonds (Hainaut and
Milner, 1993a). We now show that, in the presence of DTT
to prevent disulphide formation, chelation induced p53
aggregation (Figure 3a). Upon size fractionation on Superose
6, murine wild-type p53 normally segregates as quaternary
forms compatible with monomers, dimers and tetramersWild-type p53 conformation is temperature sensitive
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Figure 2 Sensitivity to temperature and chelation discriminates
between different forms of p53 in the wild-type conformation.
Murine wild-type p53 (a) murine temperature-sensitive allele
p53va1I35 (b) human wild-type p53 (c) and human temperature-
sensitive mutant allele p53leu27) (d) were translated in vitro in the
presence of [35S]methionine at either 37'C (a and c) or 30'C (b
and d). At 30C, p53val135 and p53Ieu273 exhibit an immunological
reactivity similar to that of the wild-type allele (Milner et al.,
1991; Medcalf et al., 1992). Aliquots of translated lysate were
exposed to varying concentrations of OP for 20 min at 25°C (0),
30°C (0), 37°C (U) or 41'C (@) and reactivity with wild-type
specific antibodies was analysed by immunoprecipitation using
PAb 246 (a and b) or PAb 1620 (c and d). p53 in immuno-
precipitates was quantified by scintillation counting and results
were expressed as a percentage of the amount of p53 precipitated
with PAb 248 (murine p53) or PAb 421 (human p53). Reactivity
with these antibodies, which recognise both wild-type and mutant
forms of p53 translated in vitro, is not affected by concentrations
of OP of up to 5 mm (see Hainaut and Milner, 1993a).
(Hainaut et al., 1994), whereas large aggregates (fraction
5-6, co-migrating with the molecular weight marker thyro-
globulin at 669 kDa) contain only 10% of the protein. After
exposure to OP in the presence of DTT, the material in
fractions 5 and 6 represented about 40% of total p53 (Figure
3a). To characterise these complexes further, p53 was expos-
ed to OP in the presence of DTT and the protein aggregates
were incubated with various dissociating agents. Large com-
plexes were separated from smaller quaternary forms by gel
filtration on Sepharose G250, which excludes globular pro-
teins and aggregates of more than 400 kDa (Figure 3b).
Dissociation of large aggregates occurred after incubation
with SDS (2%) or dimethylsuphoxide (DMSO) (10%), but
not with 100 mM DTT or in decreased pH conditions (pH 3)
(Figure 3b). These results indicate that chelation favours p53
aggregation through hydrophobic interactions, suggesting
that removal of metal ions destabilises a hydrophobic struc-
ture, permitting hydrophobic interactions between residues
normally buried within the tertiary structure.
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Figure 3 Chelation by OP induces p53 to form aggregates
through hydrophobic interactions. (a) Size fractionation profile of
wild-type p53 translated in vitro after exposure to OP. Murine
wild-type p53 translated in vitro at 37°C was exposed to OP
(2.5 mm, in the presence of 5 mM DTT to prevent the formation
of disulphide bonds). An aliquot was then applied to a Superose
6 column equilibrated in 10 mM Tris-HCI, pH 8.00, containing
150 mm sodium chloride and 0.1% NP40 and eluted into
20 x 1 ml fractions using the same buffer at a flow rate of 0.5 ml
per min. Radiolabelled p53 was precipitated from each fraction
with trichloroacetic acid and quantified by scintillation counting.
Results are expressed as percentage of total labelled p53 eluted.
White arrows indicate the position of p53 monomers (1), dimers
(2) and larger aggregates compatible with tetramers (4). Black
arrows indicate the position of size markers (in kilodaltons; for
details see Hainaut et al., 1994). *, Control; 0, + 2.5 mM OP.
(b) Dissociation of large p53 aggregates formed after metal chela-
tion. Murine wild-type p53 was translated in vitro at 37°C and
exposed to 2.5 mm OP in the presence of 5 mM DTT. Aliquots of
lysate were then incubated in various conditions as indicated and
filtered onto 10 ml G250 gel filtration columns. The excluded
material (U) (>400 kDa) was collected as a single fraction. The
material fractionated in the column (retained material, 0,
5-400 kDa) was collected in three fractions which were pooled.
The amount of excluded and retained material was evaluated by
precipitation with trichloroacetic acid and scintillation counting.
Results are expressed as the percentage of excluded or retained
material, 100% being the sum of the two.
Binding ofthe large T antigen ofsimian virus 40 protects
wild-type p53 against the effect ofOP
We have previously reported that preformed p53-DNA
complexes survive exposure to concentrations of OP which
are sufficient to disrupt the conformation of the uncomplexed
wild-type protein (Hainaut and Milner, 1993b; Hall and
Milner, 1995). This suggests that macromolecules which bind
to the central domain of wild-type p53 may regulate its
conformational stability. The large T antigen of simian virus
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Figure 4 Western blot analysis of p53 from extracts of T3T3
and SV3T3 cells after exposure to OP at 3 mm. Aliquots of
soluble cellular extracts prepared as described in the Material and
methods section were incubated for 20 min at 37°C in the
presence of 3 mmt OP before being analysed bI immunoprecipita-
tion with antibodies to p53 as indicated. PAb 421 and PAb 248
recognise both wild-type and mutant forms of p53. PAb 246 is
specific for wild-type p53 and PAb 240 recognises the 'mutant
conformation as well as denatured forms of p53. PAb 419 is
reactive with SV40 large T antigen. Immunoprecipitation of p53
with PAb 419 in SV3T3 extracts reveals the presence of com-
plexes between p53 and SV40 large T. Immunoprecipitates were
separated on 150o SDS-PAGE and electrotransferred to nitro-
cellulose. Blots were revealed with a cocktail of anti-p53
antibodies (PAb 421. PAb 240 and RA3-2C2) and 'I1-labelled
protein A.
40 binds specifically to a domain in wild-type p53 (within
residues 94-293) overlapping with the DNA-binding domain
(Ruppert and Stilman. 1993). We used extracts of SV3T3
cells as a source of preformed large T-p53 complexes to
analyse the effect of OP on p53 conformation in the presence
of large T. Figure 4 shows that binding to large T protected
the PAb 246 epitope against disruption by chelation in 3 mM
OP. In contrast, chelation disrupted the conformation of
uncomplexed p53 from T3T3 cells, as shown by the loss of
reactivity with PAb 246 and the increased reactivity with
PAb 240. Note that disruption by OP appears to favour
protein aggregation through exposure of hydrophobic
residues, as suggested by the increased non-specific reactivity
with PAb 419. These results suggest that macromolecules
interacting with the central domain of p53 may limit the
access of metal chelators to metal ions structurally bound to
p53. Alternatively, binding of large T may stabilise the PAb
246 epitope by bridging non-contiguous regions of p53.
Cell growth suppression by p53 involves sequence-specific
transcriptional regulation, a property which depends upon
the folding of the protein into a specific tertiary structure
stabilised by metal liganding (see introduction). Allosteric
regulation of p53 conformation may play a role in control-
ling p53 function. A conformational hypothesis proposes that
wild-type p53 may function to both suppress and promote
cell proliferation, a given function depending upon the con-
formation of the polypeptide (Milner. 1991). This implies
that the tertiary structure associated with suppressor function
is reversibly flexible and modulated by cellular factors which
operate during cell growth stimulation (Milner and Watson.
1990).
In this study, we show that the effect of the metal chelator
OP on wild-type p53 is a function of temperature, indicating
that temperature directly affects the conformational stability
of the wild-type polypeptide (see Results section). This sug-
gests that temperature sensitivity for conformation is an in-
trinsic characteristic of the normal p53 protein. Interestingly.
Chen et al. (1993) reported that the transactivation capacity
of a human wild-type p53 transfected in p53-null H1299 lung
cancer cells was higher at 30'C than at 37'C. Similar results
were also reported by Zhang et al. (1994) using wild-type
human p53 transfected in K562 cells. This increased transac-
tivating capacity may reflect the stabilisation of wild-type
conformation at 30°C.
A high number of murine and human p53 mutants have
been isolated which are at least partially temperature sen-
sitive for conformation and or for function between 30°C and
37C (Michalovitz et al.. 1990; Milner and Medcalf, 1990:
Martinez et al., 1991; Medcalf et al.. 1992; Chen et al.. 1993;
Zhang et al.. 1994; N Rolley and J Milner. manuscript in
preparation). These mutants may conserve the intrinsic
temperature-dependent flexibility of the wild-type polypep-
tide, but with a decreased thermostability. This decreased
stability may explain why some of these mutants exhibit
mixed wild-type and mutant properties. For example, in
HeLa cells at 30°C, p53'1135 is capable of suppressing pro-
liferation, a property of wild-type p53. but up-regulates
transcription of the interleukin 6 (IL-6) promoter, a property
which is normally associated with the mutant form of p53
(Marguiles and Sehgal, 1993).
Our results suggest that temperature influences the access
of chelators to metal ions structurally bound to p53. At low
temperature. metal ions may be tucked away in a hydro-
phobic 'pocket' inside the protein structure and may escape
chelation. As temperature increases, relaxation of p53 confor-
mation facilitates access of the chelator to the metal ions and
disruption of the protein structure. That chelation results in
protein aggregation through hydrophobic interactions indi-
cates that disruption of the metal-dependent structure des-
tabilises the core of p53 and induces hydrophobic residues to
become exposed at the surface of the molecule. The crystal
structure of human p53 reveals that hydrophobic residues
play a key role in the formation of the two frsheets which
support the DNA-binding surface of p53 (Cho et al., 1994).
It is likely that hydrophobic interactions are not sufficient to
provide a stable scaffold and that zinc binding is necessary to
hold together the different parts of the molecule, stabilising
both the DNA-binding surface and the frsheet scaffold. This
model predicts that mutations in p53 may fall into one of
three categories: (i) mutations of residues involved in metal
binding or in hydrophobic interactions, which will grossly
perturb the architecture of the molecule; (ii) mutations of
residues involved in contacting DNA, which may decrease
the affinity of p53 for specific DNA targets without inducing
major structural alterations; and (iii) 'mild' mutations located
elsewhere in the DNA-binding domain which may have a
limited structural impact: it is possible that mutants with a
decreased thermostability such as temperature-sensitive
mutants belong to this category.
The limited thermostability of wild-type p53 suggests that
variations of temperature compatible with cell survival may
affect the function of p53. That human and mouse p53 differ
by their thermostability may reflect differences in response to
thermal stress between the two species. Interestingly, hyper-
thermia (43°C) enhances the metastatic potential of rodent
tumour cells (Hahn, 1982) and exposure of both murine and
human cells to mild hyperthermia (40°-41°C) greatly enhances
cell killing induced by low doses of irradiation (Mackey et
al.. 1992; Armour et al., 1993). Mild hyperthermia affects cell
survival by altering cell cycle progression and by limiting the
efficiency of DNA repair, two processes in which p53 plays
an essential regulatory role. In contrast to UV or ionising
radiation, heat shock (42°C and 45°C) does not induce
accumulation of p53 (Lu and Lane, 1993). It is tempting to
230Wild-type p53conformation istemperaturesensitive
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speculate that mild hyperthermia enhances lethal DNA
damage induced by low-dose irradiation by destabilising
wild-type p53 conformation, thereby inhibiting its activity as
a tumour suppressor.
In conclusion, the sensitivity of wild-type p53 conforma-
tion to small changes in temperature indicates that at 37°C
the conformation of p53 depends upon an equilibrium which
can be modifed by relatively small changes in energy. Factors
affecting this equilibrium may include redox conditions and
intracellular concentrations of metal ions such as zinc and
copper (Hainaut and Milner, 1993a,b; Hainaut et al., 1995).
Furthermore, the conformational stability of wild-type p53 is
also affected by complex formation with DNA (Hainaut and
Milner, 1993b; Hall and Milner, 1995) and macromolecules
interacting with the central domain of the wild-type polypep-
tide, such SV40 large T (this paper). We propose that these
various factors cooperate in a complex network of
biochemical signals controlling the conformation and hence
the function of wild-type p53 in response to cell growth
stimulation and also to physicochemical stress.
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